What sector does Ultragenyx Pharmaceutical Inc (RARE) operate in?
Ultragenyx Pharmaceutical Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Ultragenyx Pharmaceutical Inc (RARE) current stock price?
As of the latest data, Ultragenyx Pharmaceutical Inc stock price is $32.03, with a previous close of $33.22. Ultragenyx Pharmaceutical Inc lost -$1.19 in the last trading session, representing a -3.58% loss.
What is Ultragenyx Pharmaceutical Inc (RARE) current market capitalization?
Ultragenyx Pharmaceutical Inc market cap is approximately 3.15 billion.
What is Ultragenyx Pharmaceutical Inc (RARE) Earnings Per Share (EPS)?
The trailing EPS is -$6.10, and the forward EPS is $1.55.
What is Ultragenyx Pharmaceutical Inc (RARE) EBITDA?
Ultragenyx Pharmaceutical Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -155.00 million.
Does Ultragenyx Pharmaceutical Inc (RARE) pay dividends?
No. Ultragenyx Pharmaceutical Inc does not pay a dividend.
How did Ultragenyx Pharmaceutical Inc (RARE) perform in its most recent earnings report?
In the last report (March 31, 2026), Ultragenyx Pharmaceutical Inc posted an EPS surprise of -5.48% and a revenue surprise of -12.75%.
When is Ultragenyx Pharmaceutical Inc (RARE) next earnings report?
Ultragenyx Pharmaceutical Inc is expected to release its next earnings report on June 30, 2026.
What is Ultragenyx Pharmaceutical Inc (RARE) beta (volatility) score?
Ultragenyx Pharmaceutical Inc has a beta of 0.307, indicating lower volatility than the overall market.